Unit A2 8: Histology and Pathology — The Haematology Department
Welcome to your study guide for the Haematology Department! This topic is a core component of Unit A2 8 (Histology and Pathology) in CCEA A Level Life and Health Sciences. Because Unit A2 8 is an internally assessed portfolio unit, understanding these concepts clearly will help you write high-scoring, evidence-based coursework reports.
Don't worry if medical pathology feels overwhelming at first. We will break down every concept step-by-step, explore how clinical laboratories work in the real world, and highlight exactly what you need to succeed in your portfolio.
1. What is Haematology?
Haematology is the branch of clinical pathology concerned with the study of blood, blood-forming tissues (such as bone marrow), and blood disorders. The haematology laboratory plays a critical role in hospital medicine by diagnosing and monitoring both benign (non-cancerous) and malignant (cancerous) conditions affecting red blood cells, white blood cells, platelets, and the blood clotting system.
Haematology vs. Clinical Biochemistry: Don't Mix Them Up!
A very common mistake in portfolio submissions is confusing haematology with clinical biochemistry. Remember this clear distinction:
• Haematology investigates the cellular components of blood (cells, platelets, their structure and counts) and the coagulation (clotting) system.
• Clinical Biochemistry investigates the dissolved chemical substances in liquid plasma or serum (such as electrolytes, glucose, hormones, and enzymes).
The Three Core Sub-Disciplines
In a hospital setting, the haematology department is divided into three main operational branches:
1. Diagnostic Haematology: Focuses on enumerating (counting) and analysing the size, shape, and structure of blood cells in circulation and bone marrow to diagnose conditions such as anaemias, infections, and leukaemias.
2. Haemostasis and Coagulation: Investigates disorders of blood clotting and bleeding (such as haemophilia) and monitors patients taking anticoagulant medications (like warfarin).
3. Transfusion Science (Blood Transfusion): Identifies blood groups (ABO and RhD systems), screens for red cell antibodies, and ensures safe, cross-matched blood and blood components are prepared for patient transfusions.
Key Takeaway: Haematology handles blood cells, coagulation, and blood transfusions, whereas biochemistry focuses on dissolved blood chemicals.
2. Routine Diagnostic Tests and Parameters
When a doctor orders blood tests, the haematology laboratory uses sophisticated automated analysers as well as manual microscopic techniques.
A. The Full Blood Count (FBC)
The Full Blood Count (FBC) is the fundamental screening test in haematology. It quantifies the cellular elements in a sample of whole blood. Key parameters include:
• Haemoglobin (\(Hb\)): Measured in grams per litre (\(g/L\)). This is the iron-containing oxygen-transport protein inside red blood cells. A low \(Hb\) level indicates anaemia.
• Mean Cell Volume (\(MCV\)): Measured in femtolitres (\(fL\)). This measures the average physical size of a red blood cell. It is vital for classifying different types of anaemia (microcytic, normocytic, or macrocytic).
• White Blood Cell (WBC) Differential: Measures the relative and absolute numbers of the five main types of white blood cells. Each type responds to different physiological challenges:
Memory Trick for WBCs: Use the mnemonic "Never Let Monkeys Eat Bananas" to remember the five types from most to least common in normal blood:
1. Neutrophils (fight bacterial infections)
2. Lymphocytes (fight viral infections and mediate immune memory)
3. Monocytes (differentiate into tissue macrophages)
4. Eosinophils (respond to allergic reactions and parasitic infections)
5. Basophils (release histamine during inflammatory responses)
B. The Blood Film (Blood Smear)
Automated analysers are fast, but when an abnormal result is flagged, a Biomedical Scientist prepares a blood film. A single drop of blood is spread thinly across a glass slide, stained, and examined manually under a light microscope.
A blood film allows scientists to evaluate cell morphology (shape and structure), identifying abnormalities such as:
• Sickle cells: Crescent-shaped red blood cells characteristic of sickle cell disease.
• Schistocytes: Fragmented red blood cells caused by mechanical damage in damaged blood vessels.
• Blast cells: Immature, abnormal white blood cells that can indicate acute leukaemia.
C. Coagulation Screening
To assess how effectively a patient's blood can form a clot, the coagulation bench runs specialised assays:
• Prothrombin Time (PT) / International Normalised Ratio (INR): Evaluates the extrinsic and common pathways of blood clotting. The INR is a standardised calculation derived from the PT, used worldwide to monitor patients taking the oral anticoagulant warfarin and to assess liver synthetic function.
• Activated Partial Thromboplastin Time (APTT): Evaluates the intrinsic and common clotting pathways. It is used to investigate unexplained bleeding disorders and monitor heparin therapy.
Key Takeaway: The FBC gives numbers and sizes of cells, the blood film evaluates cell shape under a microscope, and coagulation tests (PT/INR and APTT) check clotting pathways.
3. Key Blood Disorders
In your portfolio, you will need to describe how haematological tests help detect and distinguish common blood disorders. These fall into three primary categories:
1. The Anaemias
Anaemia is defined as a reduction in circulating haemoglobin concentration below the reference range for the patient's age and sex. The \(MCV\) parameter is used to classify anaemias:
• Microcytic Anaemia (Low \(MCV\)): The red cells are smaller than normal. The most common cause is Iron Deficiency Anaemia, where lack of iron prevents sufficient haemoglobin synthesis.
• Macrocytic Anaemia (High \(MCV\)): The red cells are abnormally large. Common causes include Vitamin B12 deficiency and folate deficiency, which impair normal DNA replication during red cell formation in the bone marrow.
• Sickle Cell Disease: An inherited genetic disorder where abnormal haemoglobin causes red blood cells to become rigid and sickle-shaped under low oxygen tension, causing blockages in small blood vessels and premature cell destruction.
2. Haematological Malignancies (Cancers)
• Leukaemia: Malignancies originating in the bone marrow leading to the overproduction of abnormal white blood cells. They are categorised as acute (rapidly progressing, high numbers of immature blast cells) or chronic (slower progressing, accumulation of more mature-looking abnormal cells).
• Lymphoma: Malignancies that develop primarily within the lymphatic system (lymph nodes).
• Myeloma: A cancer of plasma cells (a specialised type of B lymphocyte) in the bone marrow, often causing bone pain, kidney impairment, and abnormal immunoglobulin production.
3. Coagulation Disorders
• Haemophilia: An inherited bleeding disorder caused by a deficiency in specific clotting factors (e.g., Factor VIII in Haemophilia A), leading to prolonged bleeding into joints and muscles.
• Von Willebrand Disease: The most common inherited bleeding disorder, caused by a deficiency or dysfunction of Von Willebrand factor, a protein required for platelet adhesion to damaged vessel walls.
Key Takeaway: Categorise disorders clearly into Anaemias (classified by MCV), Malignancies (cancers of blood/marrow/nodes), and Coagulation disorders (defects in clotting factors or platelets).
4. Departmental Standards, Reference Ranges, and Quality Control
In clinical pathology, obtaining a numerical result is only half the job. The laboratory must ensure the result is reliable and interpret what it means for that specific patient.
Standard Reference Ranges
A reference range represents the set of values within which \(95\%\) of a healthy reference population falls. In your portfolio analysis, you must remember:
• Reference ranges are not universal: They vary depending on a person's age (e.g., neonates naturally have higher haemoglobin) and biological sex (e.g., adult males have higher reference intervals for haemoglobin than adult females due to hormonal influences).
• Equipment-specific differences: Different laboratory analysers, reagents, and test methods produce slight variations, meaning reference intervals are specific to each individual pathology laboratory.
Quality Assurance: IQC vs. EQA
To prevent errors and safeguard patient safety, haematology laboratories operate strict quality assurance programmes:
1. Internal Quality Control (IQC):
• Samples with known, pre-determined target values (low, normal, and high controls) are analysed every day at set intervals.
• Ensures the analyser is working with high precision and repeatability before real patient samples are run.
• If IQC values fall outside accepted limits, testing is halted until the problem is corrected.
2. External Quality Assessment (EQA):
• The laboratory receives "blind" samples from an external, independent national scheme (where the true values are unknown to the testing staff).
• The laboratory tests the sample and submits its results back to the scheme organisers to be compared against hundreds of other labs nationwide.
• Ensures long-term accuracy and consistency across the wider healthcare service.
Key Takeaway: Reference ranges depend on age, sex, and the specific lab. IQC checks day-to-day precision internally, while EQA verifies overall accuracy against outside standards.
Portfolio Checklist for Unit A2 8
When compiling your coursework evidence for the Haematology section, make sure you have:
• Clearly defined the primary role of the haematology department.
• Distinguished haematology (cellular and clotting analysis) from clinical biochemistry (dissolved chemicals).
• Explained all three branches: Diagnostic Haematology, Haemostasis/Coagulation, and Transfusion Science.
• Detailed the Full Blood Count parameters, including units (\(Hb\) in \(g/L\) and \(MCV\) in \(fL\)).
• Explained the role of blood film morphology and coagulation assays (PT/INR and APTT).
• Outlined key anaemias, malignancies, and coagulation defects.
• Discussed why reference ranges vary by age, sex, and laboratory, and explained both IQC and EQA.